Marinus Pharmaceuticals Announces Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Marinus Pharma (MRNS) 5M Common Stock Offering Prices at $6/Share
November 6, 2015 9:15 AM ESTMarinus Pharma (NASDAQ: MRNS) announced the pricing of an underwritten public offering of 5,000,000 shares of common stock for a public offering price of $6.00 per share. The net proceeds to Marinus from this offering are expected to be approximately $27.7 million, after deducting the underwriting discounts and... More
Marinus Pharma (MRNS) Poised to Open Lower After Announcing Common Stock Offering
November 6, 2015 8:20 AM ESTMarinus Pharmaceuticals, Inc. (Nasdaq: MRNS) shares are poised to open lower after announced a common stock offering. Its press release is below:
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) announced that it intends to offer and sell shares... More
